Quantcast

Latest Clinical trial Stories

2014-10-06 08:27:47

WAYNE, Pa., Oct. 6, 2014 /PRNewswire/ -- Bracket, a leading clinical trial specialty services provider, today announced the addition of Jeffrey W. Kinell as Chief Executive Officer and as a new member of its Board of Directors. Jeff brings more than 30 years of experience to Bracket, primarily in leadership positions in growth oriented, health services and pharmaceutical outsourcing firms. Most recently, Jeff was CEO of CRI Lifetree, a mid-size specialized research organization focused in...

2014-10-05 23:00:43

MarketOptimizer.org adds “Intermittent Claudication Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Intermittent Claudication. Dallas, Texas (PRWEB) October 05, 2014 New clinical trial report, “Intermittent Claudication Global Clinical Trials Review, H2, 2014″ provides data on the Intermittent Claudication clinical trial scenario. This report provides elemental information and data...

2014-10-03 23:00:25

SonaCare Medical FDA Panel Review for Its Sonablate® 450 Prostate Ablation System CHARLOTTE, NC (PRWEB) October 03, 2014 FRIDAY, OCTOBER 3, 2014 SonaCare Medical, LLC, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced that the Gastroenterology and Urology Device Panel met on Wednesday October 1st with representatives from the FDA and SonaCare Medical to review and vote on recommendations for the interim analysis of SonaCare Medical’s...

2014-10-02 23:00:46

Charity Ride Raised Funds to Support Cancer Research Goodyear, Ariz (PRWEB) October 02, 2014 GOODYEAR, AZ (October 2, 2014) – On Saturday September 27, 2014 nearly 800 cyclists of all ages and abilities took to the streets to overcome cancer at the second annual Trails 4 Trials Charity Ride (T4T) in Goodyear, Arizona. In the past two years, the event has raised more than $272,000 to help fund innovative cancer research. All donations benefited Gateway for Cancer ResearchSM, a 501(c)(3)...

2014-10-02 16:26:53

Dr. McNair to oversee WCG's team of 50 clinicians PRINCETON, N.J., Oct. 2, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services and software to support clinical research, announced today that Lindsay McNair M.D., M.P.H., M.S.B., has been promoted to chief medical officer. http://photos.prnewswire.com/prnvar/20140422/77410 "As a physician, clinical investigator, consultant, and former academic institutional review...

2014-10-02 12:31:07

Additional $12.5 Million in Matching Gifts Bring Total Commitment to $34.2 million WASHINGTON, Oct. 2, 2014 /PRNewswire-USNewswire/ -- After the generous outpouring of support from people all around the globe due to this summer's Ice Bucket Challenge, the Board of Trustees of The ALS Association has approved an initial expenditure of $21.7 million in funding to support six programs and initiatives to expedite the search for treatments and a cure for amyotrophic lateral sclerosis...

2014-10-02 08:30:08

CSSi, the leader in clinical research patient recruitment solutions, will be a featured participant and sponsor at Arena's Outsourcing in Clinical Trials New England Conference and the SCRS Site Solutions Summit. GLEN BURNIE, Md., Oct. 2, 2014 /PRNewswire/ -- CSSi (www.CSSiEnroll.com), the leader in patient recruitment solutions for the clinical research industry, is pleased to announce its participation in two upcoming industry conferences during the month of October. President...

2014-10-02 08:29:17

SAN DIEGO, Oct. 2, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a clinical-stage biopharmaceutical company, announced today that Edwin L. Parsley, D.O. has joined the Company as its Chief Medical Officer and Senior Vice President. Dr. Parsley has been actively engaged with the Company since it acquired Aires Pharmaceuticals, Inc. in February 2014. He has served as Mast's interim Chief Medical Officer since September 2014 and as Chief Medical Officer of Aires since...

2014-10-02 08:24:49

LUGANO, Switzerland, October 2, 2014 /PRNewswire/ -- Rare cancer patients need access to innovative cancer drugs A consensus paper published in the Annals of Oncology today by Rare Cancers Europe (RCE) calls for new methodologies to be applied to clinical studies in rare cancers. RCE - a multi-stakeholder initiative representing patient associations, medical societies and industry - is calling both the community of researchers and European authorities to address...

2014-10-02 00:21:35

-FREEDOM-1 study showed that ITCA 650 demonstrated positive results when added to standard oral diabetes medications. All endpoints were met regarding HbA1c and weight reductions, as well as the percent of patients treated to goal. Pre-specified sub-group analyses on HbA1c reductions over time also showed clinically and statistically significant impact across a wide spectrum of patients and background medications. Significant HbA1c reductions were observed over the 39 weeks ranging from a...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.